Avelo

Avelo2022-09-20T14:04:48+01:00

COMPANY INFO

MEDTECH – Switzerland

Current stage: Seed

AVELO

COMPANY PROFILE

Avelo is a Swiss breath diagnostics company with a mission to save lives by bringing fast and actionable infectious disease diagnoses to primary care.

NEWS

  • Avelo

Avelo is part of the new EUR 3 million “BreathForDx” project, funded by the Horizon Europe program and co-funded by SERI.

May 14th, 2024|

  • AVELO

Avelo receives CHF 1.5M Innosuisse Grant to Deliver an Innovative Breath Sampling Tool for LRTIs

December 14th, 2023|

Avelo closes CHF 2.2 million oversubscribed seed round

September 20th, 2022|